• 1

    Brand PW: “Diabetic Foot,” in Diabetes Mellitus: Theory and Practice, 3rd Ed, ed by M Ellenberg, H Rifkin, p 829, Medical Examination Publishing, New York. ,1983. .

  • 2

    Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. .JAMA 293::217. ,2005. .

  • 3

    Boulton AJ, Armstrong DG, Albert SF, et al: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. .Diabetes Care 31::1679. ,2008. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Boulton AJ, Malik RA, Arezzo JC, et al: Diabetic somatic neuropathies. .Diabetes Care 27::1458. ,2004. .

  • 5

    Game FL, Chipchase SY, Hubbard R, et al: Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. .Nephrol Dial Transplant 21::3207. ,2006. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Reiber GE, Vileikyte L, Boyko EJ, et al: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. .Diabetes Care 22::157. ,1999. .

    • PubMed
    • Search Google Scholar
    • Export Citation

What You Can’t Feel Can Hurt You

View More View Less
  • 1 Manchester Diabetes Centre, 193 Hathersage Rd, Manchester M13 0JE, England. (E-mail: ABoulton@med.miami.edu)
Restricted access

Throughout our medical training, we are taught how to manage patients who present with symptoms: perform a clinical examination, make a diagnosis, and develop a management plan. However, virtually no time is spent on teaching us how to manage patients who have no symptoms because they have lost the ability to feel pain, that is, patients with peripheral neuropathy. The lifetime incidence of foot ulceration in people with diabetes has been estimated to be as high as 25%, and a variety of contributory factors result in a foot being at risk for ulceration. Most important among these factors is peripheral neuropathy, or the loss of the ability to feel pain, temperature, or pressure sensation in the feet and lower legs. Up to 50% of older type 2 diabetic patients have evidence of sensory loss, putting them at risk for foot ulceration. If we are to succeed in reducing the high incidence of foot ulcers, regular screening for peripheral neuropathy is vital in all patients with diabetes. Those found to have any risk factors for foot ulceration require special education and more frequent review, particularly by podiatric physicians. The key message is, therefore, that neuropathic symptoms correlate poorly with sensory loss and that their absence must never be equated with lack of risk of foot ulceration. If we are to succeed in reducing the high incidence of foot ulceration and particularly recurrent ulceration, we must realize that with loss of pain there is also diminished motivation in the healing and prevention of injury. (J Am Podiatr Med Assoc 100(5): 349–352, 2010)